Skip to main content

Advertisement

Log in

The effect of n-3 fatty acids on bone biomarkers in Iranian postmenopausal osteoporotic women: a randomized clinical trial

  • Published:
AGE Aims and scope Submit manuscript

Abstract

Recently, n-3 fatty acids are in the center of attention for their potent anti-inflammatory effects. Osteoporosis as a chronic senile disease is associated with inflammation, and the role of inflammatory mediators has been demonstrated in recent years. The beneficial effects of n-3 fatty acids on bone were proven in many animal studies, while to date, no conclusive data is available in human. The aim of this study was to evaluate the impact of n-3 fatty acids on bone biomarkers in osteoporotic postmenopausal women. Twenty-five osteoporotic postmenopausal women were recruited in the study and randomized in treatment and control groups. The patients received 900 mg n-3 fatty acid capsules or placebo per day for 6 months. Serum levels of osteocalcin, bone alkaline phosphatase (BALP), calcium, vitamin D, and parathormone and urine concentration of pyridinoline (Pyd) were measured at baseline, second month, and sixth month in both groups. In the treatment group, compared with baseline, at the second month, osteocalcin increased slightly; thereafter, it showed decrement trend until the end of the study. In the control group, it decreased all over the study. None of these changes was significant. BALP showed nonsignificant decrease from baseline over the time in both groups. Urine level of Pyd decreased significantly (P < 0.05) in the treatment group, while no significant change was seen in the control group. Serum calcium and vitamin D increased in both groups; however, changes were not significant. No significant changes were seen in calcium clearance and parathormone. In conclusion, n-3 fatty acids can decrease bone resorption; however, it could not affect bone formation significantly after 6 months treatment. Further investigations are recommended.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  • Abdollahi M, Larijani B, Rahimi R, Salari P (2005) Role of oxidative stress in osteoporosis. Therapy 2(5):787–796

    Article  CAS  Google Scholar 

  • Anonymous (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795

    Article  Google Scholar 

  • Baggio B, Budakovic A, Ferraro A, Checchetto S, Priante G, Musacchio E, Manzato E, Zaninotto M, Maresca MC (2005) Relationship between plasma phospholipid polyunsaturated fatty acid composition and bone disease in renal transplantation. Transplantation 80:1349–1352

    Article  CAS  PubMed  Google Scholar 

  • Bassey EJ, Littlewood JJ, Rothwell MC, Pye DW (2000) Lack of effect of supplementation with essential fatty acids on bone mineral density in health pre- and postmenopausal women: two randomized controlled trials of Efacal® v. calcium alone. Br J Nutr 83:629–635

    Article  CAS  PubMed  Google Scholar 

  • Chrischilles E, Shireman T, Wallace R (1994) Costs and health effects of osteoporotic fractures. Bone 15(4):377–386

    Article  CAS  PubMed  Google Scholar 

  • Cremers S, Garnero P (2006) Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease. Drugs 66(16):2031–2058

    Article  CAS  PubMed  Google Scholar 

  • Eriksen EF, Gundersen HJG, Melsen F, Mosekilde L (1984) Reconstruction of the formative site in iliac trabecular bone in 20 normal individuals employing a kinetic model for matrix and mineral apposition. Metab Bone Dis Relat Res 5:243–252

    Article  CAS  PubMed  Google Scholar 

  • Gilman J, Cashman KD (2007) The effect of marine oil-derived n-3 fatty acids on transepithelial calcium transport in Caco-2 cell models of healthy and inflamed intestines. Br J Nutr 97:281–288

    Article  CAS  PubMed  Google Scholar 

  • Griel AE, Kris-Etherton PM, Hilpert KF, Zhao G, West SG, Corwin RL (2007) An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr J 6:2

    Article  PubMed  Google Scholar 

  • Hőgstrom M, Nordstrőm P, Nordstrőm A (2007) n-3 fatty acids are positively associated with peak bone mineral density and bone accrual in healthy men: the NO2 study. Am J Clin Nutr 85:803–807

    PubMed  Google Scholar 

  • Kruger MC, Coetzer H, de Winter R et al (1998) Calcium, gammalinolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging Clin Exp Res 10(5):385–394

    CAS  Google Scholar 

  • Larijani B, Moayyeri A, Keshtkar AA et al (2006) Peak bone mass of Iranian population: the Iranian Multicenter Osteoporosis Study. J Clin Densitom 9(3):367–374

    Article  PubMed  Google Scholar 

  • Lucey AJ, Paschos GK, Cashman KD, Martίnéz JA, Thorsdottir I, Kiely M (2008) Influence of moderate energy restriction and seafood consumption on bone turnover in overweight young adults. Am J Clin Nutr 87:1045–1052

    CAS  PubMed  Google Scholar 

  • Macdonald HM, New SA, Golden MH et al (2004) Nutritional associations with bone loss during the menopausal transition: evidence of a beneficial effect of calcium, alcohol, and fruit and vegetable nutrients and of a detrimental effect of fatty acids. Am J Clin Nutr 79(1):155–165

    CAS  PubMed  Google Scholar 

  • Martίnez-Ramίrez MJ, Palma S, Martίnez-González MA, Delgado-Martίnez AD, de la Fuente C, Delgado-Rodrίguez M (2007) Dietary fat intake and the risk of osteoporotic fractures in the elderly. Eur J Nutr 61(9):1114–1120

    Article  Google Scholar 

  • Salari P, Larijani B, Abdollahi M (2008a) Association of hyperhomocysteinemia with osteoporosis: a systematic review. Therapy 5(2):215–222

    Article  Google Scholar 

  • Salari P, Rezaie A, Larijani B, Abdollahi M (2008b) A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis. Med Sci Monit 14(3):RA37–RA44

    CAS  Google Scholar 

  • Shen CL, Yeh JK, Rasty J et al (2006) Protective effect of dietary long-chain n-3 polyunsaturated fatty acids on bone loss in gonad-intact middle-aged male rats. Br J Nutr 95:462–468

    Article  CAS  PubMed  Google Scholar 

  • Silverstrini G, Ballanti P, Patacchioli F et al (2005) Detection of osteoprotegerin (OPG) and its ligand (RANKL) mRNA and protein in femur and tibia of rat. J Mol Histol 36(1–2):59–67

    Article  Google Scholar 

  • Sun L, Tamaki H, Ishimaru T et al (2004) Inhibition of osteoporosis due to restricted food intake by the fish oils DHA and EPA and Perilla oil in the rat. Biosci Biotechnol Biochem 68:2613–2615

    Article  CAS  PubMed  Google Scholar 

  • Twiss JJ, Waltman NL, Berg K, Ott CD, Gross GJ, Lindsey AM (2009) An exercise intervention for breast cancer survivors with bone loss. J Nurs Scholarsh 41(1):20–27

    Article  PubMed  Google Scholar 

  • van Papendrop DH, Coetzer H, Kruger MC (1995) Biochemical profile of osteoporotic patients on essential faty acid supplementation. Nutr Res 15(3):325–334

    Article  Google Scholar 

  • Watkins BA, Li Y, Seifert MF (2006) Dietary ration of n-6/n-3 PUFAs and DHA: actions on bone mineral and serum biomarkers in ovariectomized rats. J Nutr Biochem 17(4):282–289

    Article  CAS  PubMed  Google Scholar 

  • Weiss LA, Barrett-Connor E, von Műhlen D (2005) Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults: the Rancho Bernardo Study. Am J Clin Nutr 81:934–938

    CAS  PubMed  Google Scholar 

  • Yasuda H, Shima N, Nakagawa N et al (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 95(7):3597–3602

    Article  CAS  PubMed  Google Scholar 

  • Yousefzadeh G, Larijani B, Mohammadirad A, Heshmat R, Dehghan G, Rahimi R, Abdollahi M (2006) Determination of oxidative stress status and concentration of TGF-beta 1 in the blood and saliva of osteoporotic subjects. Ann N Y Acad Sci 1091:142–150

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

This study was supported by a grant from Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences. Zahravi Pharmaceutical Company provided the drug and placebo. Authors wish to thank the physicians and nurses who helped in sampling and technicians who assisted in measurements.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pooneh Salari Sharif.

About this article

Cite this article

Salari Sharif, P., Asalforoush, M., Ameri, F. et al. The effect of n-3 fatty acids on bone biomarkers in Iranian postmenopausal osteoporotic women: a randomized clinical trial. AGE 32, 179–186 (2010). https://doi.org/10.1007/s11357-009-9122-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11357-009-9122-3

Keywords

Navigation